Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Confluent (CFLT) Shares Outstanding (Weighted Average) (2021 - 2025)

Historic Shares Outstanding (Weighted Average) for Confluent (CFLT) over the last 6 years, with Q3 2025 value amounting to $346.2 million.

  • Confluent's Shares Outstanding (Weighted Average) rose 674.64% to $346.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $346.2 million, marking a year-over-year increase of 674.64%. This contributed to the annual value of $321.9 million for FY2024, which is 702.83% up from last year.
  • Confluent's Shares Outstanding (Weighted Average) amounted to $346.2 million in Q3 2025, which was up 674.64% from $341.2 million recorded in Q2 2025.
  • Confluent's Shares Outstanding (Weighted Average)'s 5-year high stood at $346.2 million during Q3 2025, with a 5-year trough of $108.7 million in Q1 2021.
  • Its 5-year average for Shares Outstanding (Weighted Average) is $278.2 million, with a median of $297.8 million in 2023.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first surged by 15097.65% in 2022, then skyrocketed by 671.98% in 2024.
  • Confluent's Shares Outstanding (Weighted Average) (Quarter) stood at $188.6 million in 2021, then skyrocketed by 48.48% to $280.1 million in 2022, then increased by 7.37% to $300.7 million in 2023, then rose by 7.03% to $321.9 million in 2024, then grew by 7.56% to $346.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $346.2 million for Q3 2025, versus $341.2 million for Q2 2025 and $335.8 million for Q1 2025.